Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy

scientific article published on February 1, 1992

Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0022-510X(92)90286-T
P953full work available at URLhttps://api.elsevier.com/content/article/PII:0022510X9290286T?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:0022510X9290286T?httpAccept=text/xml
P698PubMed publication ID1314292

P50authorPéter LantosQ1127948
P2093author name stringP. L. Lantos
M. I. Papp
P2860cites workGlial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).Q34458365
Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophyQ39340274
A sporadic juvenile case of the amyotrophic lateral sclerosis with neuronal intracytoplasmic inclusionsQ40201686
The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid depositionQ41274250
Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosisQ41975028
Oligodendroglial Microtubular Tangles in Olivopontocerebellar AtrophyQ42466222
Lewy body-like hyaline inclusions in sporadic motor neuron disease are ubiquitinatedQ44632722
Parkinson's disease and dementia with neuronal inclusions in the cerebral cortex: Lewy bodies or Pick bodiesQ46778088
Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaquesQ48353836
Substructure of 20 nm filaments of progressive supranuclear palsyQ48538933
Classic and generalized variants of Pick's disease: A clinicopathological, ultrastructural, and immunocytochemical comparative studyQ48620412
Pick's disease. A clinical and ultrastructural studyQ48800785
Striatonigral degeneration, olivopontocerebellar atrophy and "atypical" Pick diseaseQ48821892
Immunocytochemical and ultrastructural studies of Pick's diseaseQ49040624
Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies.Q50883433
Metal-catalyzed oxidation renders silver intensification selective. Applications for the histochemistry of diaminobenzidine and neurofibrillary changes.Q53193564
Ubiquitin deposits in anterior horn cells in motor neurone disease.Q53678695
An apology and an introduction to the olivopontocerebellar atrophiesQ64763368
Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's diseaseQ67246247
Ultrastructural study of chromatolytic neurons in an adult-onset sporadic case of amyotrophic lateral sclerosisQ68385190
Immunocytochemical and ultrastructural study of Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosisQ69085749
Sporadic motor neuron disease with Lewy body-like hyaline inclusionsQ69359409
A case of diffuse Lewy body and Alzheimer's diseases with periodic synchronous dischargesQ69839018
Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosisQ70796053
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectneurologyQ83042
oligodendrocyteQ916698
P1104number of pages11
P304page(s)172-182
P577publication date1992-02-01
P1433published inJournal of the Neurological SciencesQ6296168
P1476titleAccumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy
P478volume107

Reverse relations

cites work (P2860)
Q48347991A case of multiple system atrophy with hyperglycinaemia due to a selective deficiency of glycine transporter mRNA.
Q41069719A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies.
Q40462128AMBRA1, a novel α-synuclein-binding protein, is implicated in the pathogenesis of multiple system atrophy.
Q35456966Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy
Q42481819Accumulation of phosphorylated α-synuclein in subpial and periventricular astrocytes in multiple system atrophy of long duration
Q57643175An autopsy case of preclinical multiple system atrophy (MSA-C)
Q36856567Apolipoprotein E e4 allele frequency in patients with multiple system atrophy
Q53274301Application of ubiquitin immunohistochemistry to the diagnosis of disease.
Q48579475Auditory startle responses as a probe of brainstem function in healthy subjects and patients with movement disorders.
Q73409232Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral
Q36589164Cellular pathology in multiple system atrophy
Q40724377Cellular pathology of multiple system atrophy: a review
Q28263731Chapter 33: the history of movement disorders
Q33733668Clinicopathological study of 35 cases of multiple system atrophy.
Q22007950Cloning and mapping of ZNF231, a novel brain-specific gene encoding neuronal double zinc finger protein whose expression is enhanced in a neurodegenerative disorder, multiple system atrophy (MSA)
Q64266885Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils
Q48456764Cortical and brain stem hyperexcitability in striatonigral degeneration
Q48192021Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography
Q46124320Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy
Q91429961Dissecting α-synuclein inclusion pathology diversity in multiple system atrophy: implications for the prion-like transmission hypothesis
Q48737311Distribution and dynamic process of neuronal cytoplasmic inclusion (NCI) in MSA: correlation of the density of NCI and the degree of involvement of the pontine nuclei
Q90219888Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models
Q48330336Exaggerated auditory startle responses in multiple system atrophy: a comparative study of parkinson and cerebellar subtypes
Q35627057Filamentous aggregations of phosphorylated α-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy
Q48401512Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies
Q26851153Glia and alpha-synuclein in neurodegeneration: A complex interaction
Q36703367Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain.
Q44028683Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy
Q72203939Infantile multiple system atrophy with cytoplasmic and intranuclear glioneuronal inclusions
Q34267745Interactions of Amyloidogenic Proteins
Q48390065Involvement of precerebellar nuclei in multiple system atrophy
Q56442789Multiple system atrophy
Q91252913Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines
Q26829838Multiple system atrophy: a clinical and neuropathological perspective
Q37003479Multiple system atrophy: alpha-synuclein and neuronal degeneration
Q24535446Multiple system atrophy: cellular and molecular pathology
Q47309944Multiple system atrophy: genetic risks and alpha-synuclein mutations.
Q34432121Multiple system atrophy: pathophysiology and management
Q35753409Myelin degeneration in multiple system atrophy detected by unique antibodies
Q48705357Neuronal inclusions in the dentate fascia in patients with multiple system atrophy
Q48381703Neuronal intranuclear inclusion disease: neuropathologic study of a case
Q37896515Neuropathology underlying clinical variability in patients with synucleinopathies
Q57817274Neuropsychiatric disturbances in atypical parkinsonian disorders
Q91063256Nucleophagy: from homeostasis to disease
Q38475947Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?
Q90399842PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes
Q30580363Palatal tremor, progressive multiple cranial nerve palsies, and cerebellar ataxia: a case report and review of literature of palatal tremors in neurodegenerative disease
Q42500238Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type
Q37496792Recent developments in multiple system atrophy.
Q90113476Silver staining (Campbell-Switzer) of neuronal α-synuclein assemblies induced by multiple system atrophy and Parkinson's disease brain extracts in transgenic mice
Q48270619Silver staining method for demonstrating Lewy bodies in Parkinson's disease and argyrophilic oligodendrocytes in multiple system atrophy
Q48379443Striatonigral degeneration with neurofibrillary tangles
Q58047155Tau EGFP embryonic stem cells: An efficient tool for neuronal lineage selection and transplantation
Q73826617Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
Q36876676Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease.
Q71798371Tau protein is altered by focal cerebral ischaemia in the rat: an immunohistochemical and immunoblotting study
Q41527060The Neuropathology of CAG Repeat Diseases: Review and Update of Genetic and Molecular Features
Q33592243The motor disorder of multiple system atrophy
Q45940520The neuropathology of multiple system atrophy and its therapeutic implications.
Q34231585The neuropathology, pathophysiology and genetics of multiple system atrophy
Q34048136The pathogenesis of multiple system atrophy: past, present, and future
Q34826224The role of anatomical pathology in understanding human movement disorders
Q35454079Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study.
Q42488829Tubulin immunoreactive neuronal intranuclear inclusions in the human brain
Q48291321Ubiquitin and its role in neurodegeneration.
Q40794812Ubiquitin in neurodegenerative diseases
Q71594778Ubiquitin-positive inclusions in different types of multiple system atrophy: distribution and specificity
Q33180015What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?
Q35829548Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies
Q38954592α-Synuclein: Multiple System Atrophy Prions

Search more.